EFFICACY OF ALOIN MEDIATED PHYTOGENIC NANOSILVER PARTICLES IN EXPERIMENTAL MURINE MASTITIS

Loading...
Thumbnail Image
Date
2013-02
Journal Title
Journal ISSN
Volume Title
Publisher
SRI VENKATESWARA VETERINARY UNIVERSITY , TIRUPATI – 517502. (A.P.) INDIA
Abstract
ABSTRACT : An experimental study was conducted to evaluate the efficacy of aloin mediated phytogenic nanosilver particles in experimental murine mastitis. The nanoparticles were synthesized and the synthesized nanoparticles were characterized using UV-visible spectrophotometer, Scanning electron microscope (SEM), DLS (Dynamic light scaterring) Technique and FT-IR analysis and were also evaluated for antimicrobial activity and cytotoxic effects. A total of 40 female mice between 10-15 days of lactation were utilized for the study. The animals were divided into five groups of eight animals each. Group I served as lactating control, groups II to V were inoculated with 20μl of 24h broth culture of S.aureus containing 4.0 x 104 cfu/quarter under ketamine anaesthesia using 33g blunt hamilton needle. After 6h post inoculation, groups III and IV received 20μl of Aloin nano silver (ANS) through intramammary and intra peritoneal routes respectively. Group V received antibiotic Cefepime at a dose rate of 1mg/kg body weight through intra peritoneal route. After 18 h post treatment, serum C reactive protein (CRP) levels, weights of mammary glands, mammary bacterial loads, levels of TBARS, GSH, SOD and CAT, histopathology and ultrastructure studies were conducted. UV Visible absorption spectrum showed a maximum absorption around 200 nm for ANS. SEM images showed that ANS with cubical, rectangular, triangular and spherical morphology of size 287.5 to 293.2 nm. The results of FT-IR analysis indicated the involvement of hydroxyl, carboxyl, amine and nitrile groups in the synthesis of aloin mediated silver nanoparticles. The size of the particles as measured by DLS technique was 67.8 nm. The compound (ANS) showed an MIC of 21.8 ng/ml against Staphylococcus aureus and showed an in vitro spleenocyte viability of more than 80% at the highest concentration of 87.5 ppm per well. The compound was also found to be safe at the limit dose in acute oral toxicity conducted in rats. The bacterial load was significantly reduced in ANS (intramammary), ANS (intra peritoneal) and antibiotic group compared to mastitis control. The levels of C-Reactive Protein were significantly reduced in Aloin treatment groups III and IV compared with antibiotic group V. TBARS was not significantly reduced to the level of normal lactating group, however SOD and CAT levels were lowered by both routes of aloin nanosilver (ANS) treatments. In histopathological sections, significant reduction (98%) in PMN infiltration was observed with ANS than antibiotic (50%). Ultrastructure of mammary gland from aloin treatment groups III and IV indicated moderate progress in the architecture of the secretory epithelial cells showing reconstituting mitochondria and normal inter alveolar septa.
Description
THESES
Keywords
Citation
Collections